Glycan Sequencing Market

Glycan Sequencing Market: Global Industry Analysis 2014 -2018 and Opportunity Assessment; 2019 - 2029

  • Ongoing
  • September 2020
  • REP-GB-10027
  • Format: PDF/PPT/Excel

  • US$5,000
  • US$7,500
  • US$10,000

This Glycan Sequencing market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Glycan Sequencing market.

Minor glycan sequencing is carried out in order to determine the characteristics and functionalities of glycan present in glycoconjugates. The wide variety of glycosylation causes hindrance in the elucidation procedure and hence requires the addition of other orthogonal methods to ensure clarity in the glycan profile. The techniques involved in glycan sequencing are high performance liquid chromatography, Mass spectrometry, and electrophoresis. These methods involve digestion through enzymes such as exoglycosidase. Any changes in glycan structure and their identification can be responsible for diseases. Glycans and glycan binding protein are linked to some disease diagnosis. They aren’t the primary precursors of disease but can add clarity to diagnosis reports. Some pathogens present in GI tract recognize glycans and can be a factor in dealing with this genre of diseases. Glycan sequencing can provide aid in studying these aspects. Epithelial ovarian cancer ranks fifth in the cancers related to women. The glycans present in the membrane are exposed to alteration during carcinogenesis and hence cancer is the field of scope for glycan sequencing market.

Glycan Sequencing Market: Drivers and Restraints

The growing prevalence in glycobiology carrying out studies of different carbohydrate and protein is a driver of glycan sequencing market. The introduction of new researches in the field of proteomics in North America, Europe, East Asian regions is a major driver of glycan sequencing market. The analysis of non- inheritable diseases in protein level is prevalent in a considerable number of regions and is a major driver for glycan sequencing market. The increasing expenditures in healthcare is a driver for glycan sequencing market. The increasing awareness of cancer research especially ovarian cancer is a driver for glycan sequencing market. The importance of glycan sequencing in biopharmaceuticals due to the attraction of pathogen towards unusual glycan sequences is a potential driver for this market. Biopharmaceuticals is a growing field and have potential for growth of glycan sequence market. The glycobiology of glycans are partially linked with development immunology and can be a driver for the glycan sequencing market. Proteoglycans have functional importance in neurobiology and can have a scope for glycan sequencing market.

  • Identify Key Market Forces and their Long-Term Forecast
  • Sneak Peek into Key Forecast Factors and thier Impact

COVID -19 : Impact Analysis

Request the coronavirus impact analysis across industries and markets

Request Covid -19 Impact

Glycan Sequencing Market: Overview

The glycan sequencing technologies are of key importance in metabolomics. Glycan sequencing market has key importance in studying the structural and physical frame of various biological processes. Enzymatic procedures are the most common methods for glycan sequencing. They are more feasible methods for glycan sequencing. Some unusual sequences of glycan are more prone to toxins and pathogens and hence there is scope for glycan sequencing market in biopharmaceuticals. There is a wide range of disorders resulting due to glycosylation and hence the role of glycan sequencing in diagnostic centers. They are involved in the identification of some cancer biomarkers. The glycans which are present in membranes are vulnerable to carcinogenesis in some cases. These aspects are driving the market for glycan sequencing.

Glycan Sequencing Market: Regional Overview

North America is expected to be the dominant market in glycobiology research. Europe also contributes considerably to the field of proteomics. These two regions can be a key region for glycan sequencing market to grow. The United Kingdom has a significant number of research centres involved in metabolomics and can be a dominant area for glycan sequencing market. There are some metabolomics research centers originating in China. Japan also has a significant number of research labs in metabolomics. East Asia can be a profitable market for glycan sequencing market.

Glycan Sequencing Market: Key Players

Some of the Key players in the glycan sequencing market include

  • Merck & Co Inc
  • Charles River
  • New England Biolabs
  • Lake Pharma Inc
  • Biocompare and Promega Corporation

The research report on glycan sequencing market presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report on glycan sequencing market provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on glycan sequencing market:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Report includes regional analysis:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Europe (Germany, Italy, France, U.K, Spain, , Russia)
  • East Asia (China, Japan, South Korea)
  • South Asia (India, ASEAN)
  • Oceania (Australia, New Zealand)
  • Middle East and Africa (GCC Countries, South Africa, Northern Africa)

The report on Glycan Sequencing market is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Unique Requirements? Customize this Report

  • Customize by Region, Country, Application, Product, & other segments
  • Integrate our Insights with your Existing Data
  • Determine the scope of the study to suit your requirements

Let FMI Help You!

  • Gain Insights on Key Glycan Sequencing Market Impacting Forces
  • Know the Winning Strategies of Market Leaders
  • Get Deep-Dive Analysis on Each Segment
  • Identify the Sources that will Drive Top-Line Revenue

Glycan Sequencing Market: Segmentation

The global glycan sequencing market is classified on the basis of types of sequencing, application and end user and geographic region.

Based on Types of sequencing, the glycan sequencing market is segmented into:

  • By using enzyme Endoglycoceramidase
  • Hydrazinolysis 
  • Alkaline Borohydride Treatment
  • By using enzyme Endoglycosidase
  • By using Exoglycosidase

Based on application, the glycan sequencing market is segmented into:

  • Glycobiology
  • Proteomics
  • Neurobiology
  • Developmental Immunology
  • Biotherapeutics
  • Antibody production

Based on end user, the glycan sequencing market is segmented into:

  • Research centers
  • Academic Institutes
  • Diagnostic Centers
  • Cancer Research Labs

Report on glycan sequencing market highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint
Frequently Asked Questions

Why choose FMI?
  • With a global presence and a trusted partner to several Fortune 500 firms, FMI covers 1 billion+ data points to build a diversified portfolio for market benchmarking
  • Market Reports researched and peer reviewed by industry experts from across the globe
  • We follow a multi-dimensional method of analysis monitoring a three-layer data validation process
  • In addition to demand-side market assessment, our data triangulation methodology involves supply-side research
  • Primary research includes mandatory field interviews with stakeholders involved
  • Customizing reports according to client specification is also our forte
  • The current and future market size, covering each aspect and nuanced trends across key national and geographic markets
  • An overview of the market report, providing an imperative visual of the varied market subdivisions and overall forecast statistics in terms of value and volume
  • Extensive database and key dynamics elevating the market with varied verticals associated
  • Underlying Glycan Sequencing Market forces that are compelling consumers or businesses to purchase the product
  • How novel technologies and consumer-centric innovations will create new value-adding opportunities for companies active in the Glycan Sequencing Market
  • What will be environment and regulatory impacts on the market over the next decade
  • Investment Feasibility Matrix - It shows returns on investment, level of competition, success rate of investment, and potential risks associated with the market. The analysis shows that the competition is high in the established market, while the returns for short-term investment are also taken into consideration
  • Relative Maturity Mapping – The relative maturity is measured according to three growth phases (growth, maturity, decline)
  • Relative PLC (Product Life Cycle) – Analysis of the emergence of prominent players and competitive test prices which are driving factors behind every market. (expected market behavior, observed market behavior, expected market performance, observed market performance)
Get in touch

Harish Tiwari

Global Head - Business Development

Akshay Godge

Client Partner - Global Business Development

Our Clients

Request Sample Request customization Request Methodology